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It is well established that the endothelium responds to mechanical forces induced by
changes in shear stress and strain. However, our understanding of vascular remodeling
following traumatic brain injury (TBI) remains incomplete. Recently published studies
have revealed that lung and umbilical endothelial cells produce extracellular microvesicles
(eMVs), such as microparticles, in response to changes in mechanical forces (blood flow
and mechanical injury). Yet, to date, no studies have shown whether brain endothelial
cells produce eMVs following TBI. The brain endothelium is highly specialized and
forms the blood-brain barrier (BBB), which regulates diffusion and transport of solutes
into the brain. This specialization is largely due to the presence of tight junction
proteins (TJPs) between neighboring endothelial cells. Following TBI, a breakdown in
tight junction complexes at the BBB leads to increased permeability, which greatly
contributes to the secondary phase of injury. We have therefore tested the hypothesis
that brain endothelium responds to mechanical injury, by producing eMVs that contain
brain endothelial proteins, specifically TJPs. In our study, primary human adult brain
microvascular endothelial cells (BMVEC) were subjected to rapid mechanical injury to
simulate the abrupt endothelial disruption that can occur in the primary injury phase
of TBI. eMVs were isolated from the media following injury at 2, 6, 24, and 48 h.
Western blot analysis of eMVs demonstrated a time-dependent increase in TJP occludin,
PECAM-1 and ICAM-1 following mechanical injury. In addition, activation of ARF6,
a small GTPase linked to extracellular vesicle production, was increased after injury.
To confirm these results in vivo, mice were subjected to sham surgery or TBI and
blood plasma was collected 24 h post-injury. Isolation and analysis of eMVs from blood
plasma using cryo-EM and flow cytometry revealed elevated levels of vesicles containing
occludin following brain trauma. These results indicate that following TBI, the cerebral
endothelium undergoes vascular remodeling through shedding of eMVs containing TJPs
and endothelial markers. The detection of this shedding potentially allows for a novel
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methodology for real-time monitoring of cerebral vascular health (remodeling), BBB
status and neuroinflammation following a TBI event.
Keywords: blood-brain barrier (BBB), traumatic brain injury, mechanical strain, extracellular microvesicles, tight
junction proteins, neuroinflammation
INTRODUCTION
TBI represents a serious medical concern for patients and has
both short-term (disorientation, memory loss etc.) and long-term
(disability, loss of productivity etc.) effects. The pathology of TBI
is due to a combination of primary (mechanical) and subsequent
secondary (biochemical and cellular) effects. While previous TBI
research has focused on damage to neurons, recent evidence has
highlighted the central role of vascular integrity and changes in
BBB permeability in delayed neuronal death and dysfunction
(Shlosberg et al., 2010). In some cases, BBB dysfunction can last
for months or years following the original injury (Korn et al.,
2005). Prolonged BBB permeability can contribute to edema
formation and result in cytotoxicity and further neuronal damage
(Unterberg et al., 2004). Such observations are not only limited to
cases of moderate or severe TBI, but can also be seen within the
mild spectrum of TBI, including concussive and sub-concussive
injuries. Part of its pathologic description commonly mentions
the lack of radiological presentation of a hematoma, however
this does not eliminate the possibility that the BBB has not been
compromised. In fact, recent findings in mild TBI research have
revealed the existence of micro-tears, which are small gaps or
separations observed between endothelial cells, and sites of BBB
breach (Glushakova et al., 2014; Liu et al., 2016). Thus, all forms
of TBI at both the primary phase (induced by forces that are linear
or rotational) and the secondary phase (a result of inflammation)
trigger changes to the BBB, particularly at the level of single cell
thick capillaries.
The brain endothelium is unique from other endothelium in
that it has highly enriched levels of tight junction proteins (TJPs)
such as occludin, claudin (Cld -3, -5 and -12), zonula occludens
proteins (ZO-1, -2), and junctional adhesion molecules (JAM;
Abbott et al., 2006). BBB integrity and formation of tight
junctions (TJ) between endothelial cells (ECs) are vital for proper
barrier function. However, our understanding of howmechanical
injury and the secondary biochemical changes that occur in TBI
affect TJs and TJPs remains unclear.
It is thought that all or most cells produce extracellular
microvesicles (eMVs), which include microparticles and
exosomes, in response to stimuli, activation, and injury. The
release of eMVs has been shown to result from upstream
signaling involving cytoskeletal remodeling and activation of
GTPases RhoA and ARF6 (Boshans et al., 2000; Muralidharan-
Chari et al., 2009; Latham et al., 2013; Ghossoub et al., 2014).
Previous reports have shown that lung and umbilical ECs
produce microparticles in response to mechanical stimuli
(physiological shear stress and cyclic strain) in vitro (Vion
et al., 2013a,b; Letsiou et al., 2015) and in vivo (Jenkins et al.,
2013). In addition, an immortalized brain endothelial cell line
(hCMEC/D3) has been shown to produce microparticles in
response to cytokine and agonist stimulation (Latham et al.,
2013). However, to date, no studies have shown whether brain
ECs produce eMVs following TBI or whether eMVs contain
TJPs that may reflect changes in BBB integrity. A recent study
has shown elevated levels of the TJP occludin in the serum
following a mild TBI (Shan et al., 2016); however, the eMV
protein expression profile was never investigated.
To test whether TBI induces the release of brain endothelial-
derived eMVs, we utilized an in vitro model that simulates
tissue deformation caused by rapid changes in linear strain (such
as that produced in TBI) applied to human brain endothelial
cells (BMVECs). The model consists of BMVECs grown on
elastic membranes that are deformed by vacuum to deliver
a rapid injury. Our results indicate that the injury induces a
time-dependent release of eMVs containing the TJP occludin.
In addition, we detected elevated levels of endothelial markers
in eMVs and increased endothelial activation of the small
GTPase protein ARF6. Next, we confirmed the elevated release
of occludin in vivo using the controlled cortical impact model
of TBI. In addition, cryo-EM and immune-gold labeling of
occludin demonstrated localization of occludin in eMVs from
blood plasma following a TBI event. Overall, these results suggest
that TJPs from cells that form the BBB are readily produced
and detectable following mechanical injury to the endothelium.
Importantly these findings also reveal the potential for using
brain endothelial-derived eMVs as biosignatures for monitoring
the health of the BBB not only during brain injury but possibly
for other neurological conditions as well.
MATERIALS AND METHODS
Reagents
Rat-tail collagen I and endothelial cell growth supplement
(ECGS) were purchased from BD Biosciences (Franklin Lakes,
NJ). Heparin and bovine serum albumin (Sigma), DMEM/Ham’s
F12 media, Fetal bovine serum (FBS; Thermo Fisher Scientific,
Waltham, MA).
Endothelial Cell Culture
Primary human adult brain microvascular endothelial cells
(BMVECs) were provided by Michael Bernas and Dr. Marlys
Witte (University of Arizona, Tucson). BMVECs were isolated
from vessels from the brain resection path of patients (showing
no abnormalities) undergoing surgery for the treatment of
intractable epilepsy, as previously described (Bernas et al., 2010).
Isolation of cells and tissue and the use of BMVECs has been
approved by Temple University and the University of Arizona’s
IRB committees. BMVECs were grown in Dulbecco’s modified
Eagle’s medium/F12 media supplemented with 10% heat-
inactivated fetal bovine serum (FBS; Thermo Fisher Scientific),
endothelial cell growth supplement (ECGS; BD Bioscience),
heparin (1mg/mL; Sigma/Aldrich Co, Ltd), amphotericin B
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(2.5µg/mL; Thermo Fisher Scientific), penicillin (100U/mL;
Thermo Fisher Scientific), and streptomycin (100µg/mL;
Thermo Fisher Scientific).
In vitro Mechanical Strain-Induced Injury
Model
BMVECs were plated on Collagen I coated 6-well Flexcell plates
(Flexcell International Corporation) and grown until confluence.
The day before all experiments, media was exchanged with 10%
FBS in DMEM F12 and then all experiments were conducted
in 1% FBS DMEM F12. Endothelial cells were rapidly injured
using a 1 s gradient biaxial strain (12 or 22% substrate elongation)
exerted by vacuum application to the chamber using the Flexcell
Tension System FX-5000 (Flexcell International Corporation).
Percentage of Elongation is defined by the following equation:
%Elongation =
Lfinal − Linitial
Linitial
∗ 100
Where L is the length of the substrate. The elongation of the
membrane is a function of the applied force (from the vacuum)
and the elasticity of the membrane. The following equation
describes the force applied based on the vacuum pressure exerted:
F = 0.177 ∗ P ∗ D2
Where F is the force applied in lbs, P is the pressure inMPa
and D is the diameter of the sample in mm. The required
force to achieve the desired % elongation is pre-programed by
the manufacturer based on specifications for the Flexcell plates.
Following injury, cells and media were harvested at time points
(5min and 2, 6, 24, 48 h) and processed for further analysis. For
eMV harvest, media was spun at 2000 × g for 20min to remove
cellular debris and the supernatant was snap frozen and stored
at−80◦C. ARF6 activation was determined using a G-LISA assay
(Cytoskeleton Inc., Denver, CO) following the manufacturer’s
protocol. A constitutively active ARF6 protein provided with the
assay was used as a positive control.
Live Cell Imaging and
Immunocytochemistry
For visualization of live cells after injury, cells were incubated
with 1µM of the cell tracker dye, Calcein-AM (Thermo Fisher
Scientific) for 20min prior to injury. Images were taken prior to
and 2 h post injury. For immunocytochemistry, cells were fixed
with 4% paraformaldehyde at 2 h post injury. The cells were then
permeabilized with 0.1% triton for 10min and then non-specific
binding was blocked using 5% BSA for 30min. Incubation of
cells with primary antibodies to ZO-1 (BD Biosciences) was then
performed overnight at 4◦C. After rinsing at least three times
with 1x PBS the cells were incubated with species specific Alexa-
488 conjugated secondary antibodies for 1 h at RT (Thermo
Fisher Scientific), rhodamine conjugated phalloidin for 1 h at RT
(Cytoskeleton, Inc.) followed by counterstaining with nuclear dye
DAPI for 30min. Cells were then rinsed three times in 1x PBS and
mounted in Prolong Antifade (Thermo Fisher Scientific) prior
to coverslipping. All images were captured using a Coolsnap EZ
CCD camera (Photometrics, Tucson, AZ) coupled to a Nikon
80i Eclipse (Nikon, Japan) and processed using the NIS Elements
imaging software (Nikon).
Flow Cytometry of BMVECs
Metabolic activity assay: metabolic activity was determined
using the dye C12-resazurin, which converts to red-fluorescent
C12-resorufin in metabolically active cells (Thermo Fisher
Scientific). Cells were rinsed with 1x PBS and then trypsinized.
C12-resazurin was added (to a final concentration of 500 nM)
and cells were incubated for 15min at 37◦C. Cells were
washed and placed on ice and the fluorescence output was
measured immediately. Cell Death Assay: % of dead cells was
determined using STOX R© Green, a green-fluorescent nuclear
and chromosome counterstain that is impermeant to live cells
(Thermo Fisher Scientific). Detached cells were pelleted from the
media and combined with adherent cells, which were removed by
trypsinization. STOX R© Green was added to a final concentration
of 10 nM and cells were incubated for 15min at 37◦C. Cells
were then washed, placed on ice and the fluorescence output
was measured immediately. Surface expression immunostaining
of ICAM-1: Cells were rinsed with calcium and magnesium
free 1x PBS, trypsinized and then pelleted by centrifugation at
1000 rpm for 5min. Cells were then resuspended in fixation
buffer (eBioscience Inc., San Diego, CA) and incubated for
10min. Following fixation, cells were washedwith flow cytometry
buffer (eBioscience) and centrifuged as above. Cells were
resuspended in 100µL of flow cytometry buffer with an ICAM-1
preconjugated antibody to R-phycoerythrin (PE; eBioscience) for
1 h. Cells were then rinsed, centrifuged and resuspended in flow
cytometry buffer for flow cytometry analysis. Data was acquired
with a FACS BD Canto II flow cytometer (BD Biosciences)
and analyzed using the FlowJo software (Tree Star, Ashland,
OR, USA).
Western Blot of eMVs
eMVs were isolated using the Exoquick-TC system from
System Biosciences Inc. (Mountain View, CA) following the
manufacturer recommendation. eMVs were isolated from
equal media volumes produced from equal cell numbers in
order to control for differences in quantities of eMVs produced
between conditions. All cell counts were obtained using an
automated cell counter (Scepter, EMD Millipore, Billerica MA).
The eMVs were then centrifuged and resuspended in Cell
Lytic MT Cell Lysis Reagent (Sigma). Lysed eMVs were then
mixed with 4x Laemmli buffer and boiled for 5min at 95◦C.
Samples were loaded onto a 4–20% Mini-Protean TGX gel
(Biorad, Hercules, CA). Gels were transferred to nitrocellulose
membranes using the Trans-blot Turbo™ transfer system
(Biorad) following the manufacturer’s protocol. Membranes
were blocked with 5% nonfat dry milk in PBST (0.5%) and
all primary and secondary antibodies were resuspended in
5% nonfat dry milk in PBST (0.5%). Primary and secondary
antibodies used were as follows: occludin (abcam, Cambridge,
UK, rabbit, 1:1000), PECAM-1 (Santa Cruz Biotechnology Inc.,
Santa Cruz, CA, goat 1:1000), ICAM (Santa Cruz Biotechnology
Inc., rabbit 1:1000), goat-HRP (Jackson ImmunoResearch
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1:10,000) rabbit-HRP (GE Healthcare, Princeton, NJ,
1:10,000). HRP-conjugated antibodies were detected using
Supersignal West Pico chemiluminescent substrate (Thermo
Fisher Scientific) and visualization of luminescent signal
was obtained using the gel documentation system, G:Box
Chemi HR16 (Syngene, Frederick, MD). Densitometry
was performed with the image analysis software, Image J
1.48v (NIH).
Controlled Cortical Impact (CCI) Mouse
Model of Traumatic Brain Injury
The Institutional Animal Care and Use Committee (IACUC) at
Temple University (Philadelphia, PA) approved all procedures
detailed in this section that required the use of vertebrate
animals prior to initiating any experimental objectives. Animals
were weighed prior to surgery to obtain a baseline for
monitoring animal wellness following CCI procedures. Animals
were anesthetized using a 1:2 solution of ketamine (100mg/ml)
to xylazine (10mg/ml; Henry Schein Animal Health; Dublin,
OH) administered by intraperitoneal (IP) injection at a dose
of 1ml/kg. Depth of anesthesia was monitored throughout
the surgical procedure by hind paw toe pinches to assure
that animals remained properly anesthetized. Animals were
shaved to remove hair from the scalp surrounding the surgical
area and immobilized using a Mouse™ Stereotaxic Instrument
(Stoelting Co.; Wood Dale, IL). Ophthalmic ointment (Dechra
Veterinary Products; Overland Park, KS) was applied to the eyes
to prevent ocular drying. Seventy percent isopropyl alcohol was
used to clean the scalp, neck, and ears. A Zeiss Stemi 2000-
C stereomicroscope (Carl Zeiss Microscopy, LLC; Thornwood,
NY) equipped with a Schott EasyLED Ringlight (SCHOTTNorth
America Inc.; Elmsford, NY) was used to magnify and illuminate
the surgical site. Surgical instruments were autoclaved prior to
use and sterilized between animals using a Hot Bead Sterilizer
(Fine Science Tools Inc.; Foster City, CA). Surgical scissors were
used to remove a portion of the scalp and expose the skull from
the sagittal suture to the right temporalis muscle. The underlying
fascia was removed, and an Ideal Micro-Drill™ (CellPoint
Scientific Inc.; Gaithersburg, MD) with a 0.5mm, rounded
burr was used to create a 4mm craniotomy between bregma
and lambda suture lines. The surgical area was periodically
washed with 1X PBS, and drill time was minimized in order
to avoid overheating of surrounding tissue. The bone fragment
resulting from the craniotomy was carefully lifted away from the
underlying brain to avoid disrupting the dura and cortical tissue.
Any animal sustaining additional injury to the brain during
craniotomy procedures was excluded from the study. An Impact
One™ Stereotaxic CCI Instrument (Leica Microsystems; Buffalo
Grove, IL) outfitted with a piston (2mm diameter) was secured
to the stereotaxic stage and positioned over the exposed parietal
somatosensory cortex. The piston was oriented parallel to the
cortical plane and lowered until contact was made with the dural
surface. TBI was delivered with the following parameters: impact
velocity: 5 m/s, impact depth: 1mm, impactor tip diameter:
2mm, dwell time: 0.50 s. After discharging the impactor piston,
the site of injury was covered by a sterile, 5mm glass coverslip
(Electron Microscopy Sciences; Hatfield, PA), which was secured
to the skull using Vetbond™ tissue adhesive (3 M; St. Paul,
MN), creating a waterproof seal between the glass coverslip and
the surgical margins of the scalp. After adhering the coverslip
atop the craniotomy, animals were removed from the stereotaxic
stage and place in their home cage, resting upon an isothermal
pad (Braintree Scientific, Inc.; Braintree, MA) to maintain body
temperature during recovery. Animals were monitored in their
home cage until consciousness was regained. Surgical control
(craniotomy only) procedures included all of the steps described
above except impactor discharge. Blood was collected from the
inferior vena cava into an insulin syringe containing 20µl of
0.5M EDTA to prevent clotting. Whole blood was spun at
1500 × g for 20min and plasma was transferred to a sterile
microcentrifuge tube, snap frozen, and stored at −80◦C for
later use.
Flow Cytometry of eMVs from Blood
Plasma
eMVs were isolated using the Exoquick system (System
Biosystems, Inc.) following the manufacturer’s protocol. In short,
blood plasma was incubated with Exoquick for 30min at 4◦C.
After isolation, eMVs were centrifuged at 1500 × g for 30min
and resuspended in 100µL of flow cytometry buffer with primary
antibody Occludin (abcam) for 1 h. FITC conjugated Secondary
antibody (eBioscience) was added for 30min. 200µL of flow
cytometry buffer was added and the samples were analyzed by
flow cytometry. Events were acquired for each sample with a
FACS BDCanto II flow cytometer (BD Biosciences) and analyzed
with FlowJo software (Tree Star, Ashland, OR, USA).
Cryo-EM of eMVs from Blood Plasma
Post-TBI
Isolated eMVs were resuspended in 100µL of buffer containing
20mM Tris pH 7.4 and 150mM Na/KCl. eMVs were incubated
with rabbit anti-occludin antibody (abcam) for 1 h followed
by incubation of anti-rabbit IgG (H&L) conjugated to 10 nm
gold nanoparticles (Cytodiagnostics Inc., Ontario, Canada) for
30min. eMVs were prepared by high pressure freezing (or
cryo-frozen) and analyzed by electron microscopy (EM) at the
Electron Microscopy Resource Laboratory (EMRL) headed by
Dr. Dewight Williams with technical support by Ray Meade.
The EMRL is part of the University of Pennsylvania Biomedical
Research Core Facilities.
Statistical Analysis
The experiments were independently performed multiple times
(at least three times for all the data shown) to allow
statistical analyses. Within each individual experimental set,
every condition was evaluated in three replicates. The data
collected were analyzed using Prism v6.0c (GraphPad Software,
San Diego, CA). Multiple group comparisons were performed by
two-way analysis of variance (ANOVA) with post-hoc analysis
or students t-test where indicated. All the results are expressed
as the mean ± SEM with differences considered significant
at p < 0.05.
Frontiers in Cellular Neuroscience | www.frontiersin.org 4 February 2016 | Volume 10 | Article 43
Andrews et al. Injury Induces Brain-Endothelial Microvesicle Release
RESULTS
Characterization of Brain Endothelial
Status Following an in vitro Model of
Mechanical Injury
To model the type of linear kinetic forces that lead to stretching-
strain deformation of tissue during the primary phase of TBI, a
Flexcell R© Tension System FX-5000 (from Flexcell International
Corp.) was utilized. This approach tested the ability of mature
monolayers of primary human brain microvascular endothelial
cells (BMVECs) to sustain rapid changes in mechanical strain
for which micro-tears would be the observable outcome. In
addition, this model utilizes a single layer of BMVECs and
mimics capillary walls, which are likely key sites of vulnerability
in mechanical injury during TBI. Similarly to physiological
conditions, mature BMVECs (as described previously) in the
above culture conditions display all normal BBB characteristics.
Therefore, BMVECs grown on collagen type I coated silicone
membranes were subjected to biaxial strain generated by vacuum
pump negative pressure, (Figure 1A schematic of cells at rest,
top, and under strain, bottom). Figure 1B shows the degree of
deformation (membrane elongation profile) when mechanical
stimulation was initiated by a semi-sinusoidal tensile stretch
pulse lasting 1 s. Profiles are shown for stimulation frequencies
of 1.0 and 0.5Hz, corresponding to membrane elongation of
12 and 22% respectively. Next, the BMVECs were assayed for
the presence of micro-tears after mechanical insult. For better
visualization of BMVECs, the cells were loaded with the cell
tracker Calcein-AM, which labels and allows the cells to be
imaged by fluorescence microscopy. A continuous BMVEC
monolayer can be seen in the undisturbed or uninjured control
(Figure 3A). In contrast, both the 12 and 22% elongation
increased micro-tear formation between adjacent cells (white
arrows). In addition, an increased number of swollen or enlarged
cells can readily be seen following the 22% elongationmechanical
injury (yellow arrows). Taken together, these results confirm
that strain deformation at either 12 or 22% elongation induces
marked effects to brain endothelial cells in the form of micro-
tears and cellular swelling.
Mechanical Injury Affects Intercellular
Tight Junctions (TJs)
The physical manifestation of the BBB is due to the presence of
tight junction proteins (TJPs) between neighboring endothelial
cells (Persidsky et al., 2006). Tearing or dysfunction of the
BBB in essence is suggestive of disconnected and disassembled
TJs (Aghajanian et al., 2008). To assess whether discontinuity
or absence of junctions were evident post mechanical strain,
immunocytochemistry analysis of ZO-1 was performed at
2 h following insult. These studies were also compared with
morphological changes, mainly the appearance of stress fibers.
As expected in the uninjured control, intense immunopositive
staining of the tight junction protein, ZO-1, can be found
at the perimeter or junctional areas of every cell (Figure 2).
Although ZO-1 is a cytosolic protein, its critical role is to
anchor membrane tetraspanin tight junction proteins and thus it
FIGURE 1 | An in vitro model of inducing mechanical biaxial strain. (A) Schematic of the FlexcellTM injury device. Endothelial cells are grown on elastic silicone
membranes that are deformed using negative pressure. (B) Stretch profile of the injury model. Two stretch parameters were used: 12 and 22% membrane elongation.
Injury was performed by applying vacuum over 1 s. (C) Calcein-AM labeling of endothelial cells before and after injury. Uninjured cells are confluent and continuous
with neighboring endothelial cells (left). Following 12% (middle) and 22% (right) stretch, miro-tears between adjacent endothelial cells develop (white arrows) and at the
higher elongation, some cells appear to be swollen (yellow arrows).
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FIGURE 2 | In vitro injury to BMVECs induces F-actin stress fiber
formation and disruption of tight junctions. Staining of uninjured BMVECs
(left panels) shows actin localized primarily at the cell borders where it
colocalizes with the tight junction protein ZO-1 (white arrows). In addition,
minimal stress fibers along the length of the cell are visible and ZO-1 staining
localized at the cell borders (yellow arrows) is typical of that seen in barrier
forming BMVECs. Following injury by 22% membrane stretch (right panels),
BMVECs develop clear and distinct F-actin stress fibers (red arrows) and ZO-1
redistributes to a punctate pattern at cell borders with diffuse expression
across the cell (yellow arrowheads).
appears junctional (Fanning et al., 1998). Notably, uninjured cells
have minimal F-actin stress fiber formation, and instead retain
more cortical appearing actin. Meanwhile, BMVECs that had
undergone strain-elongation had increased F-actin stress fiber
formation (red arrows) and ZO-1 was no longer junctional or
co-localized with actin. In addition, the normal intense ZO-1
immunostained pattern became punctate and absent following
mechanical insult (yellow arrowhead). Therefore, evaluation of
docking TJP, ZO-1 showed that TJ complexes are disrupted as a
consequence of increased strain.
To determine whether micro-tears and TJ damage resulting
from strain induces changes to metabolic activity, BMVECs were
evaluated at the acute (24 h) phase of mechanical injury with
fluorescence reporter PE-C12-resazurin. Analysis of cells by flow
cytometry showed that strain decreased metabolic activity as
measured by a decrease in the mean fluorescence intensity (MFI)
of PE-C12-resazurin fluorescence (Figures 3A,B). The results
showed a 30 and 50% decrease in mean fluorescence intensity
(MFI) for 22 and 12% stretch, respectively when compared to
control. Together these results support the notion that in addition
to disrupted tight junctions, changes in cellular energetics also
occur due to mechanical injury in BMVECs. Of note, analysis
of cell death did not show any significant loss of BMVECs
following biomechanical injury at any of the points investigated
(Figures 3C,D).
Mechanical Injury Induces a
Time-Dependent Release of eMVs
Containing TJPs and Endothelial Markers
from Brain ECs
To evaluate whether mechanical injury induces the release of
eMVs from BMVECs, BMVECs were subjected to the strain
parameters characterized earlier (12 and 22% stretch) and cells
and media were collected at the times indicated. As an initial
aspect of the secondary phase of TBI, endothelial cells upregulate
surface expression of ICAM-1. This is thought to occur in order
to recruit immune cells to sites of inflammation (Whalen et al.,
1999). Interestingly, the overall surface expression of ICAM-
1, as determined by flow cytometry, decreased on BMVECs
following strain, trending downward as early as 2 h and reaching
significance at 6 h. ICAM-1 expression remained decreased at
48 h post strain (Figures 4A–D). This effect on ICAM-1 surface
expression followed the same trend for both mechanical insults
tested. Conversely, ICAM-1 expression on shed eMVs isolated
from the media was significantly increased, thus inversely
correlating to the observation in cellular expression (Figure 4E).
Further analysis of the isolated eMVs showed the presence
of endothelial marker PECAM-1 and tight junction protein
occludin following injury (Figures 5A,B). PECAM-1 expression
in eMVs was increased rapidly (at 2 h) and persisted at elevated
levels (Figure 5A). The increase in occludin, however, was time-
dependent and peaked at 24 h post injury (Figure 5B).
The involvement of the small GTP-protein ARF6 in both
vascular permeability and microvesicle formation has been
recently documented (Muralidharan-Chari et al., 2009; Akers
et al., 2013; Ghossoub et al., 2014). Therefore, it was examined
whether ARF6 would also play a role in BMVEC eMV shedding
following changes in mechanical strain. ARF6 activity was
measured using a G-LISA assay that captures ARF6 and then
detects ARF6 bound to GTP with another specific antibody.
Activation of ARF6 increased significantly by 38% 5min after
the cells were subjected to biaxial strain. Constituently active
ARF6 was used as positive control for the assay. (Two-tailed t-test
average ± SEM Static 0.3362 ± 0.0540, n = 6, 22% stretch
0.4644 ± 0.07, n = 3 ∗p < 0.05, positive control 0.7279 ±
0.0787, n = 2). The results from this assay point to the possible
involvement of ARF6 in eMV biogenesis resulting from kinetic
forces acting on brain endothelium.
Extracellular Microvesicles (eMVs)
Containing Occludin are Detected in Blood
Plasma Following TBI
A recent study has indicated that elevated levels of occludin
are detectible in the blood of patients following a mild TBI
(Shan et al., 2016). Importantly, the above study did not measure
occludin in isolated eMVs. To determine if occludin was released
in eMVs following TBI, blood plasma was collected 24 h after
experimental TBI using the controlled-cortical impact (CCI)
mouse model. Purified eMVs were analyzed by flow cytometry
and cryo-EM. Figures 6A–E, shows the results from flow-
cytometry analysis comparing the levels of occludin positive
eMVs detected in blood plasma of sham versus CCI-TBI mice.
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FIGURE 3 | In vitro endothelial injury decreases metabolic activity without inducing cell death in BMVECs. (A) PE mean fluorescence intensity (MFI), a
measure of cell metabolic activity, was analyzed in injured and uninjured BMVECs using flow cytometry. Injured cells exhibited reduced red fluorescence intensity
reflecting a decrease in metabolic activity, which converts C12-resazurin to red-fluorescent C12-resorufin. A positive control (0.1% Triton X-100), which disrupts cell
membranes and reduces metabolic activity, was used to verify the assay (One-way ANOVA and Tukey post-hoc test average ± SEM uninjured n = 8, 12% n = 5, 22%
n = 6, *p < 0.05, **p < 0.01). (B) Representative histograms of PE-C12-resazurin MFI for each condition. (C) Cell death was determined using STYOX
® Green, a
green fluorescent nuclear and chromosome counterstain, was used to determined the percentage of dead cells. A positive control (2mM H2O2) was used to induce
cell death. (One-way ANOVA and Sidak post-hoc test average ± SEM uninjured n = 4, 12% n = 5, 22% n = 6). (D) Representative dot plots are shown for each
condition.
Two clear occludin positive populations were detected and were
designated as either high or low forward side scatter (FSC). FSC
is related to the amount of laser passing around the vesicle and
is thus related to its size. Analysis of occludin positive vesicles
showed a 5-fold increase high-FSC vesicles (Figure 6C) and a
7.5-fold increase in total occludin positive vesicles (Figure 6B)
following CCI-TBI as compared to sham. Size beads (ranging
from 0.22 to 1.34µm diameter) were used to estimate the size of
occludin positive vesicles (Figure 6D). Occludin positive vesicles
appeared to be predominately smaller than 0.45µm diameter.
To further characterize the morphology of eMVs produced
following TBI, indirect imaging by high-resolution cryo-EM
which has previously been used to visualize extracellular vesicles
can provide information regarding eMV size, structure, and
composition (Issman et al., 2013). As can be seen in the sample
cryo-EM image shown (Figure 6E), eMVs had diameters ranging
between 50 and 300 nm. Furthermore, immunogold labeling
clearly outlined occludin positive vesicles primarily in the size
range of 100–300 nm in diameter (Figure 6E). Of note, not all
eMVs in the sample image show immunoreactivity for occludin,
indicating the possibility that these eMVs may be from other
cellular sources other than brain endothelium. These analyses
provide strong in vivo evidence for the presence and robust
production (at 24 h) of occludin containing eMVs in the blood
serum of animals following CCI-TBI. The data also demonstrates
for the first time visual confirmation of isolated eMVs highly
enriched with the tight junction protein occludin (i.e., as seen by
the presence of immunogold antibodies to occludin).
DISCUSSION
Prior studies have demonstrated the significance of BBB damage
following TBI. However, our understanding of the effects of
mechanical injury on cerebral vascular endothelium remodeling
remains incomplete. We have therefore utilized both in vitro and
in vivo approaches to study responses of the cerebral endothelium
to mechanical injury. Here we present compelling results that
demonstrate that brain endothelial cells release eMVs containing
the TJP occludin in response to biaxial strain (as a means to
simulate the primary or kinetic induced injured that is seen in
TBI) and the controlled cortical impact animal model of TBI.
Devices that involve deformation of a cellular support
membrane (Winston et al., 1989; Schaffer et al., 1994; Brown,
2000) are commonly used to study the effects of physiological
strain on endothelial cells (Vion et al., 2013a; Figueroa et al.,
2014) and TBI-like injury on neurons and glial cells (Ellis et al.,
1995; Geddes-Klein et al., 2006; Cullen et al., 2007). Only recently
have these devices been used to model the effects of TBI on
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FIGURE 4 | Reduced surface expression of ICAM-1 and induced production of eMVs containing ICAM-1 following in vitro biomechanical injury of
brain endothelial cells. (A–D) show surface ICAM-1 expression by flow cytometry, histograms and bar graph representation for the following time points post injury:
(A) 2 h, (B), 6 h (C), 24 h (D) 48 h (two-tailed t-test *p < 0.05 average ± SEM at rest n = 4, 12, and 22% stretch n = 3 at t = 2 and 6 h, n = 4 t = 24 h, n = 6 t = 48 h)
(E) eMVs were collected from the media at the indicated time points and analyzed by western blot. Injured cells released greater quantities of ICAM-1, which was time
and stretch dependent. (Two-way ANOVA and students t-test *p < 0.05, **p < 0.01, average ± SEM Static n = 5, 12% n = 4, and 22% n = 5 except one outlier was
excluded for 12% t = 48 h and 22% t = 2 h using Grubb’s test p < 0.05).
endothelial cells (Salvador et al., 2013, 2015). Characterization
of the injury induced from the in vitro mechanical strain model
used in this study reproduces the type of linear kinetic forces
that induces micro-tears to the endothelium in TBI (Figure 1).
Indeed we also observed that mechanical injury induced changes
inmetabolism resulting frommembrane damage (Figures 3A,B).
While not significantly significant, there was a trend for a greater
decrease in metabolic activity from 12% substrate elongation as
compared to 22% elongation. It is unclear if this is a result of small
differences in the membrane elongation profile achieved using
our experimental set-up or if it is a real endothelial physiological
response to mechanical injury. Furthermore, stretch injury
models such as these typically do not increase cell death even
on neuronal cells subjected to strain/stretch ranging from 0 to
50% (Geddes-Klein et al., 2006). We also saw no increase in cell
death following substrate elongation (Figures 3C,D). Instead,
many endothelial cells appeared to be swollen following injury
(Figure 1), which has been reported by others both in vitro
(Salvador et al., 2013, 2015) and in vivo (Simard et al., 2010).
This change in cell volume is theorized to alter cytoskeletal
dynamics and weaken tight junctions leading to the increased
barrier permeability (Simard et al., 2010).
Short-term studies (24–72 h) have found that in vitro and
in vivo models of TBI decrease endothelial expression of
TJPs (occludin, ZO-1, and Cld-5; Higashida et al., 2011; Hue
et al., 2013; Wen et al., 2014; Salvador et al., 2015) and
result in discontinuous ZO-1 staining in histological analysis
of brain tissue (Thal et al., 2012). We also observed disrupted
tight junctions and a transition of ZO-1 expression from
continuous localization along cell borders to a discontinuous,
punctate, and even absent expression pattern (Figure 2). These
changes in ZO-1 localization and subcellular distribution
were accompanied by decreased colocalization with F-actin
(Figure 2). The colocalization of F-actin with TJPs has been well
documented, and actin has been proposed to play a critical role
in maintaining TJ complex integrity and stability (Lai et al.,
2005). While TJP disassembly and expression changes have been
reported to occur following TBI, it has been unclear whether TJPs
are degraded internally or processed and packaged to be released
extracellularly. Here we present for the first time evidence that
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FIGURE 5 | In vitro mechanical injury induces the release of eMVs containing the endothelial marker PECAM-1 and tight junction protein
occludin. (A) Injury increases the release of eMVs containing PECAM-1. eMVs were isolated from media using Exoquick and analyzed by western blot.
Elevated levels of PECAM-1 were detected at 2 h and remained elevated for most time points. (Two-way ANOVA with Bonferroni post-hoc analysis **p < 0.01
average ± SEM Static and 22% n = 6, 12% n = 4) (B) Injury induces a time-dependent increase in eMVs containing occludin. eMVs were isolated from the
media using Exoquick at the indicated time points post-injury and analyzed by western blot. Statistically significant increases were seen at 6, 24, and 48 h
after injury. (Two-way ANOVA with Bonferroni post-hoc analysis *p < 0.05, **p < 0.01 average ± SEM Static and 22% n = 6, 12% n = 4 except for 12%
t = 24 h where one outlier was excluded using Grubb’s test p < 0.05).
both in vitro, via mechanically induced strain (Figure 5), and
in vivo, using a leading model of experimental TBI (Figure 6),
mechanical injury increases the release of eMVs containing the
TJP occludin.
The endothelium is constantly exposed to mechanical forces
such as shear stress and strain and consequently remodels in
response to these mechanical forces. The production of eMVs by
endothelial cells following mechanical stimuli has only recently
been investigated in the context of physiological shear stress and
cyclic strain in vitro (Vion et al., 2013a,b; Letsiou et al., 2015)
and in vivo (Jenkins et al., 2013). Other studies have shown that
human pulmonary and umbilical endothelial cells (HUVECs)
respond to mechanical forces to produce microparticles and that
themechanism of cyclic stretch-induced vesicle release is thought
to be activated by the release of TNF-α and other cytokines
(Wang et al., 2003; Dignat-George and Boulanger, 2011). A
recent study using an in vitro TBI model on endothelial cells
showed an increase in TNF-α and CCL2 mRNA production 24 h
post injury (Salvador et al., 2015). TNF-α and other inflammatory
cytokines are known to induce the upregulation of ICAM-1 in
brain ECs (Ramirez et al., 2012; Rom et al., 2015). Therefore,
we anticipated that ICAM-1 surface expression would be
upregulated following mechanical injury. However, we observed
a decrease in ICAM-1 surface staining, which corresponded
to an increase in shedding of ICAM-1 in eMVs (Figure 4).
Upregulation of ICAM-1 and other adhesion molecules by
the cerebral endothelium following a TBI is well established
(Carlos et al., 1997). An important distinction between our
work and previous studies utilizing in vitro TBI models is that
our data reflects changes in primary human BMVECs vs. an
immortalized murine brain ECs line (Salvador et al., 2013, 2015).
In addition, Salvador et al. (2015) detected increased mRNA for
inflammatory cytokines but they did not evaluate other indices
of endothelial activation such as cytokine release or protein
expression of adhesion molecules (Salvador et al., 2015). The lack
of ICAM-1 induction in brain ECs has led us to hypothesize
that in the absence of other neurovascular unit (NVU) members
(i.e., microglia, astrocytes), brain ECs likely initiate repair or
angiogenic mechanisms without activation. This is supported
by studies showing the production of by cytokines produced by
other cells of the NVU (Carlos et al., 1997), a contribution which
is lacking in our in vitro experimental model. Therefore, as basal
cellular surface levels of ICAM-1 decrease via shedding of eMVs,
brain ECs may only upregulate ICAM-1 in response to signals
from other injured cells (i.e., microglia, astrocytes, and neurons)
or by recruited immune cells. In summary, increased eMV
production in response to mechanical injury was observed in
both in vitro and in vivo models and represents an understudied
aspect of the consequences of TBI.
The profile of ICAM-1 release in eMVs was similar at both
12 and 22% elongation while the profile of PECAM-1 and
occludin had differential changes. Specifically, at 12% elongation,
PECAM-1 release remained relatively constant at all time points
while 22% elongation induced a graded release that peaked at
6 h. Occludin expression in eMVs was also a graded response,
which peaked earlier in response to 12% as compared to 22%
elongation. While it might be expected that eMV release would
be linear in response to mechanical injury, where greater injury
induces greater release for all proteins, little is known regarding
this process. Our results provides some initial insight into the
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FIGURE 6 | Experimental TBI induces the release of eMVs containing the tight junction protein occludin. Mice were subjected to sham surgery or a
Controlled Cortical Impact, CCI-TBI and blood was collected 24 h post-injury. (A) Flow Cytometry detection of occludin (FITC) positive eMVs from blood plasma.
Regions of interest were drawn around all FITC positive vesicles as well as a clear high FSC population. (B,C) TBI induces an increase in total FITC positive and high
FSC-FITC positive vesicles at 24 h post-injury (Students two-tailed t-test average ± SEM n = 5 for sham and n = 4 for TBI, *p < 0.05, **p < 0.01, one was excluded
from the sham group for being a significant outlier). (D) Occudin (FITC) positive vesicles (shown in red) were compared to beads of known size ranging from 0.22 to
1.34µm in diameter. (E) eMVs isolated post-TBI were analyzed using cryo-EM and immunogold labeling to show occludin positive microvesicles.
response of brain ECs to strain in vitro and in vivo, and further
investigation would provide a more thorough understand of the
kinetics of eMV release from mechanical injury.
Regarding extracellular vesicles, two main categories have
been identified based on their size and mechanism of release.
Microparticles (MPs) are the larger of the two categories ranging
between 0.1 and 1µm in diameter and are generated by outward
blebbing of the plasma membrane. Exosomes are smaller (30–
100 nm) and are released by vesicular fusion with the plasma
membrane (Raposo and Stoorvogel, 2013). In this study we have
not focused on identifying the type of extracellular vesicle that
contains the TJP occludin or endothelial markers (PECAM-1,
ICAM-1). A number of studies have reported on the localization
of both PECAM-1 and ICAM-1 in MPs (Jimenez et al., 2003).
Our flow cytometry data of occludin positive eMVs from
blood plasma (Figure 6A) identified two clear populations based
on size. However, standard flow cytometers do not have the
resolution to accurately identify exosomes based on their small
size. Thus it is unclear if the two populations reported by flow
cytometry here translate to the two types of vesicles. Occludin-
immunogold labeling and cryo-EM imaging (Figure 6E) showed
occludin positive vesicles that fall into the size category of
both types of extracellular vesicles. Aside from identifying
occludin positive vesicles, a number of vesicles detected by
these methods appeared to be multivesicular which has been
shown previously (Issman et al., 2013). Of note, the detection
of immunogold labeled vesicles that appeared to be inside
another vesicle likely reflects two vesicles stacked on top of one
another (arrow) instead of a multivesicular vesicle (arrowhead).
In addition, some vesicles appeared to be more granular than
others which suggests differences in content (Issman et al.,
2013).
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The mechanism of extracellular vesicle release has been linked
to cytoskeletal rearrangement (Boulanger et al., 2006; Latham
et al., 2013) as well as small GTPases such as Rho (Burger et al.,
2011) and ARF6 (Pasquier et al., 2014). ARF6 has been linked
to both microvesicles (Pasquier et al., 2014) and exosome release
(Friand et al., 2015). In the case of microvesicles, ARF6 activation
leads to downstream phospholipase D and ERK signaling, MLC
activation and finally acto-myosin contraction at the vesicle
neck and the release into the extracellular space (Muralidharan-
Chari et al., 2009). For exosomes, ARF6 and phospholipase D2
control the budding of intraluminal vesicles into multivesicular
bodies. Multivesicular bodies will later fuse with the membrane
to release the exosomes extracellularly (Ghossoub et al., 2014).
Based on the evidence for ARF6 involvement in extracellular
vesicle release we analyzed ARF6 activation and found that it
was elevated following injury (Results Section). The activation
of ARF6 and detection of eMVs following injury contributes to
our understanding of the effects of mechanical damage to the
endothelium.
We believe that the results presented here represent a
significant advancement to our understanding of cerebral
vascular remodeling following TBI. In addition, our approach
to understanding the effects of TBI is highly BBB and
endothelial centric and offers the potential to uncover new
biomarkers for the monitoring and diagnosis of TBI. The field
of TBI research has indeed recognized the lack of available
effective biomarkers for diagnosing and monitoring a patient
following brain injury (Forde et al., 2014), and many prior
studies have focused on biomarkers related to neuronal and
astrocytic damage with few focused on biomarkers specific
for BBB damage. Cardiovascular research has spearheaded
studies focusing specifically on endothelial damage and the
production of extracellular vesicles as a diagnostic and prognostic
tool for hypertension, atherosclerosis, diabetes, and endothelial
dysfunction (Boulanger et al., 2006; Chironi et al., 2009).
Numerous studies have shown that endothelial cells (pulmonary,
umbilical, artery, aortic) release eMVs in response to a number of
insults including inflammatory cytokines, mechanical injury, and
serum deprivation (Chironi et al., 2009). In these studies, eMV
levels are typically determined by Annexin V (microparticles;
Draeger et al., 2011) or exosome markers (CD63, Alix, etc.),
which are general markers and are therefore not cell or organ
specific. Some studies have proposed the differentiation of the
cell lineage by cell specific markers such as P-selectin (CD62P)
and CD63 for platelets (Tan et al., 2005) and PECAM-1 (CD31)
for endothelial cells (Boulanger et al., 2006). Here, we propose an
alternative method of eMV detection and identification by TJPs.
Coupled with endothelial markers and other proteins enriched
at the BBB, this approach delineates eMV origin, primarily from
brain ECs, and also has the potential to reflect the functionality
of the host cell and provide a clinically useful assessment of BBB
status in TBI. Detection of brain endothelial-derived eMVs could
provide a novel means to analytically evaluate BBB health in a
number of CNS conditions that are associated with trauma and
neuroinflammation.
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